DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rallied 1.69% to $223.59 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.66% to 7,773.95 and the Dow Jones Industrial Average rising 0.18% to 51,267.90.
The stock's rise snapped a four-day losing streak.
Biogen Inc. closed 2.99% short of its 52-week high of $230.49, which the company achieved on September 28th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.21% to $252.93, Pfizer Inc. $(PFE)$ fell 1.40% to $27.41, and AbbVie Inc. $(ABBV)$ rose 1.12% to $265.76.
Trading volume (936,991) remained 12,733 below its 50-day average volume of 949,724.
Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.